CN1318388C - 在光化学疗法中作为光敏剂的5－氨基乙酰丙酸的酯类 - Google Patents

在光化学疗法中作为光敏剂的5－氨基乙酰丙酸的酯类 Download PDF

Info

Publication number
CN1318388C
CN1318388C CNB018146953A CN01814695A CN1318388C CN 1318388 C CN1318388 C CN 1318388C CN B018146953 A CNB018146953 A CN B018146953A CN 01814695 A CN01814695 A CN 01814695A CN 1318388 C CN1318388 C CN 1318388C
Authority
CN
China
Prior art keywords
amino
compound
ester
group
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB018146953A
Other languages
English (en)
Chinese (zh)
Other versions
CN1460099A (zh
Inventor
J·克拉文尼斯
N·O·尼尔森
J·E·布莱顿
A·戈达尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Photocure ASA
Original Assignee
Photocure ASA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photocure ASA filed Critical Photocure ASA
Publication of CN1460099A publication Critical patent/CN1460099A/zh
Application granted granted Critical
Publication of CN1318388C publication Critical patent/CN1318388C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNB018146953A 2000-07-27 2001-07-25 在光化学疗法中作为光敏剂的5－氨基乙酰丙酸的酯类 Expired - Fee Related CN1318388C (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0018528.0 2000-07-27
GB00185280 2000-07-27
GBGB0018528.0A GB0018528D0 (en) 2000-07-27 2000-07-27 Compounds

Publications (2)

Publication Number Publication Date
CN1460099A CN1460099A (zh) 2003-12-03
CN1318388C true CN1318388C (zh) 2007-05-30

Family

ID=9896500

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB018146953A Expired - Fee Related CN1318388C (zh) 2000-07-27 2001-07-25 在光化学疗法中作为光敏剂的5－氨基乙酰丙酸的酯类

Country Status (19)

Country Link
US (2) US7217736B2 (cg-RX-API-DMAC7.html)
EP (1) EP1313695B1 (cg-RX-API-DMAC7.html)
JP (1) JP5010088B2 (cg-RX-API-DMAC7.html)
KR (1) KR20030028554A (cg-RX-API-DMAC7.html)
CN (1) CN1318388C (cg-RX-API-DMAC7.html)
AT (1) ATE349417T1 (cg-RX-API-DMAC7.html)
AU (2) AU2002227495B2 (cg-RX-API-DMAC7.html)
CA (1) CA2416307C (cg-RX-API-DMAC7.html)
CZ (1) CZ2003260A3 (cg-RX-API-DMAC7.html)
DE (1) DE60125555T2 (cg-RX-API-DMAC7.html)
DK (1) DK1313695T3 (cg-RX-API-DMAC7.html)
ES (1) ES2276844T3 (cg-RX-API-DMAC7.html)
GB (1) GB0018528D0 (cg-RX-API-DMAC7.html)
HU (1) HUP0301427A2 (cg-RX-API-DMAC7.html)
NO (1) NO20030398L (cg-RX-API-DMAC7.html)
NZ (1) NZ523927A (cg-RX-API-DMAC7.html)
PT (1) PT1313695E (cg-RX-API-DMAC7.html)
RU (1) RU2246483C2 (cg-RX-API-DMAC7.html)
WO (1) WO2002010120A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104718190A (zh) * 2012-09-03 2015-06-17 埃克塞特大学 用于光动力疗法的吡啶酮化合物

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6492420B2 (en) * 1995-03-10 2002-12-10 Photocure As Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
DK1126826T6 (en) * 1998-11-02 2019-06-24 Alkermes Pharma Ireland Ltd Multiparticulate modified release of methylphenidate
US20090297602A1 (en) * 1998-11-02 2009-12-03 Devane John G Modified Release Loxoprofen Compositions
ATE380029T1 (de) 2001-06-11 2007-12-15 Xenoport Inc Prodrugs von gaba-analoga, zusammensetzungen und ihre verwendungszwecke
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7232924B2 (en) 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
GB0118251D0 (en) * 2001-07-26 2001-09-19 Photocure Asa Method
CA2500908A1 (en) * 2002-10-04 2004-04-22 Elan Pharma International Limited Gamma irradiation of solid nanoparticulate active agents
DE10312659A1 (de) * 2003-03-21 2004-10-07 Universität Regensburg 5-Aminolävulinsäurederivate und ihre Verwendung
EP1626742A1 (en) 2003-05-22 2006-02-22 Elan Pharma International Limited Sterilization of dispersions of nanoparticulate active agents with gamma radiation
CA2437638A1 (en) 2003-08-20 2005-02-20 John Robert North Photodynamic therapy
CA2457214A1 (en) 2004-02-06 2005-08-06 Qlt Inc. Photodynamic therapy for the treatment of acne
GB0406917D0 (en) 2004-03-26 2004-04-28 Photocure Asa Compounds
JP2005350418A (ja) * 2004-06-11 2005-12-22 Shibuya Kogyo Co Ltd 標的細胞の死滅方法と標的細胞を死滅させるための薬剤及び該薬剤の製造装置
ES2459366T3 (es) 2004-09-02 2014-05-09 Cosmo Oil Co., Ltd. Agentes mejoradores de la función constitutiva
CN102429882B (zh) 2004-11-04 2015-03-25 什诺波特有限公司 加巴喷丁前体药物持续释放口服剂型
GB0424833D0 (en) 2004-11-10 2004-12-15 Photocure Asa Method
US20080254114A1 (en) * 2005-03-03 2008-10-16 Elan Corporation Plc Controlled Release Compositions Comprising Heterocyclic Amide Derivative Nanoparticles
JP4934292B2 (ja) * 2005-07-05 2012-05-16 コスモ石油株式会社 ５−アミノレブリン酸エステルリン酸類塩、その製造方法及びその用途
JP4934293B2 (ja) * 2005-07-05 2012-05-16 コスモ石油株式会社 植物活力剤組成物
GB0609809D0 (en) * 2006-05-17 2006-06-28 Photocure Asa Product
CA2657409A1 (en) * 2006-07-12 2008-01-17 Elan Corporation, Plc Nanoparticulate formulations of modafinil
JP5404995B2 (ja) 2006-08-10 2014-02-05 コスモ石油株式会社 植物のポリフェノール増量剤
GB0700580D0 (en) 2007-01-11 2007-02-21 Photocure Asa Use
US20090036952A1 (en) 2007-07-30 2009-02-05 National Yang-Ming University Induction driven light module and use thereof
GB0718957D0 (en) * 2007-09-28 2007-11-07 Ge Healthcare Ltd Optical imaging agents
KR100883560B1 (ko) * 2007-08-23 2009-02-17 (주) 위디어 신규한 5-아미노레불린 산 유도체 및 이의 제조방법
GB0724279D0 (en) * 2007-12-12 2008-01-23 Photocure Asa Use
CA2709274A1 (en) * 2007-12-14 2009-06-25 Photoderma Sa Novel compounds useful in therapeutic and cosmetic methods
GB0804190D0 (en) * 2008-03-06 2008-04-16 Ge Healthcare Ltd Ester imaging agents
EP2305237B1 (en) 2008-05-14 2014-04-30 SBI Pharmaceuticals Co., Ltd. Therapeutic agent for male sterility
WO2010024775A1 (en) * 2008-09-01 2010-03-04 Swedish Pharma Ab New 5-aminolevulinic acid prodrugs for use in photodynamic therapy and photodynamic diagnosis
GB0823472D0 (en) 2008-12-23 2009-01-28 Photocure Asa Product
GB0900461D0 (en) 2009-01-12 2009-02-11 Photocure Asa Photodynamic therapy device
EP2440199B1 (en) * 2009-06-11 2016-04-13 Photocure ASA Semi-solid compositions and pharmaceutical products
SG176687A1 (en) * 2009-06-11 2012-01-30 Photocure Asa Solid compositions comprising 5-aminolevulinic acid
CA2790827A1 (en) * 2010-03-01 2011-09-09 Photocure Asa Cosmetic compositions
EP2394642A1 (en) 2010-06-10 2011-12-14 Universite De Geneve 5-ALA ester formulations and use thereof
WO2011161220A1 (en) 2010-06-23 2011-12-29 Photocure Asa Hyperosmotic preparations comprising 5 -amino levulinic acid or derivative as photosensitizing agent
WO2012004399A1 (en) 2010-07-09 2012-01-12 Photocure Asa Dry compositions and devices containing such dry compositions for use in photodynamic therapy or photodynamic diagnosis
EP2657346B1 (en) 2010-12-24 2017-08-23 ARKRAY, Inc. Method for detecting cancer cell
CN103607999A (zh) 2011-01-13 2014-02-26 Qlt股份有限公司 局部递送光敏剂的药物组合物及其用途
WO2013053927A1 (en) 2011-10-14 2013-04-18 Photocure Asa Photodynamic diagnosis of abnormalities of the epithelial lining of the oesophagus with the means of a 5-ala ester
US20140316534A1 (en) 2011-10-14 2014-10-23 Photocure Asa Stent
RU2615870C2 (ru) 2011-12-19 2017-04-11 ФотоКьюэр АСА Устройство облучения
WO2013092936A2 (en) 2011-12-20 2013-06-27 Galderma Research & Development Use of 5-aminolevulinic acid and esters, in combination with a vitamin d derivative or analog in photochemotherapy, and their uses in treating acne
EP2872178A1 (en) 2012-07-11 2015-05-20 Dermira, Inc. Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof
NZ629914A (en) 2012-08-03 2017-02-24 Photocure Asa New derivatives of 5-aminolevulinic acid and their use as photosensitizing agents
GB201221123D0 (en) 2012-11-23 2013-01-09 Photocure As Device for photodynamic treatment
GB201306369D0 (en) 2013-04-09 2013-05-22 Photocure As Irradiation device
JP6595484B2 (ja) 2013-12-20 2019-10-23 ガルデルマ・リサーチ・アンド・デヴェロップメント 光損傷皮膚のパルス光力学的処置
EP3102195B1 (en) 2014-02-03 2021-10-06 Quadriga Biosciences, Inc. Beta-substituted beta-amino acids and analogs as chemotherapeutic agents
EP3095464A1 (en) 2015-05-19 2016-11-23 Universite De Geneve 5-ala derivatives and use thereof
AU2016302243B2 (en) 2015-08-03 2019-07-11 Quadriga Biosciences, Inc. Beta-substituted Beta-amino acids and analogs as chemotherapeutic agents and uses thereof
GB201522309D0 (en) * 2015-12-17 2016-02-03 Photocure Asa Use
GB201522398D0 (en) 2015-12-18 2016-02-03 Photocure As Device for photodynamic therapy
CN112010772A (zh) 2016-01-26 2020-12-01 赵鸣 5-氨基酮戊酸及其衍生物的盐化合物和应用
WO2018141988A1 (en) 2017-02-06 2018-08-09 3Skin As Sunscreen composition
ES2965514T3 (es) * 2017-06-21 2024-04-15 Photocure Asa Procedimiento de preparación de una composición farmacéutica líquida y dispositivo para su uso en dicho procedimiento
EP3868372A1 (en) 2020-02-19 2021-08-25 JLP Health GmbH A pharmaceutical combination of an artemisinin compound and a heme synthesis modulator for treating cancer
CN111635464B (zh) * 2020-05-12 2022-03-25 上海易全化学有限公司 一种5-氨基酮戊酸葡聚糖酯的制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0316179A2 (en) * 1987-11-10 1989-05-17 Tokuyama Soda Kabushiki Kaisha Photochromic compounds
JPH0753487A (ja) * 1993-08-19 1995-02-28 Cosmo Sogo Kenkyusho:Kk 植物成長調節剤
WO1996028412A1 (en) * 1995-03-10 1996-09-19 Photocure As Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2411382C3 (de) 1974-03-09 1979-09-06 C.H. Boehringer Sohn, 6507 Ingelheim 2-Tetrahydrofurfuryl-6,7-benzomorphane, Verfahren zur Herstellung und deren Verwendung
US4087532A (en) * 1974-03-09 1978-05-02 Boehringer Ingelheim Gmbh Analgesically useful 2-tetrahydrofurfuryl-5-lower alkyl-2-oxy-6,7-benzomorphans and salts thereof
GB2058077B (en) 1979-06-08 1983-03-09 Szelke M Enkephalin analogues
CA1236029A (en) * 1984-05-14 1988-05-03 Edmund Sandborn Pharmaceutical solutions comprising dimethyl sulfoxide
SE460947B (sv) 1986-08-26 1989-12-11 Lejus Medical Ab En multiple-unit-dos komposition av l-dopa
JPS6452778A (en) * 1987-05-30 1989-02-28 Tokuyama Soda Kk Fulgide compound and production thereof
US5422093A (en) * 1989-07-28 1995-06-06 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US5955490A (en) * 1989-07-28 1999-09-21 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US5079262A (en) 1989-07-28 1992-01-07 Queen's University At Kingston Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid
US5234940A (en) 1989-07-28 1993-08-10 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
JP2767318B2 (ja) 1990-04-11 1998-06-18 株式会社コスモ総合研究所 ５―アミノレブリン酸アルキルエステル又はその塩及びその製造方法並びにこれを有効成分とする除草剤
NZ240057A (en) 1990-10-05 1994-07-26 Univ Kingston Tetrapyrrole derivatives
US5219878A (en) * 1990-10-05 1993-06-15 Queen's University Tetrapyrrole hydroxyalkylamide photochemotherapeutic agents
GB9318841D0 (en) 1993-09-10 1993-10-27 Res Foundation Of The Norwegia Composition
JP2896963B2 (ja) * 1994-11-28 1999-05-31 株式会社コスモ総合研究所 植物の耐塩性向上剤
US6492420B2 (en) * 1995-03-10 2002-12-10 Photocure As Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
GB9504948D0 (en) * 1995-03-10 1995-04-26 Norwegian Radium Hospital Rese Compounds
US6992107B1 (en) * 1995-03-10 2006-01-31 Photocure Asa Esters of 5-aminolevulinic acid and their use as photosensitizing compounds in photochemotherapy
US7530461B2 (en) 1995-03-10 2009-05-12 Photocure Asa Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
GB9700396D0 (en) * 1997-01-10 1997-02-26 Photocure As Photochemotherapeutic compositions
FR2777782B1 (fr) 1998-04-22 2001-05-18 Alexandre Marti Solution pour la preparation d'une substance pharmaceutique pour le diagnostic et/ou le traitement de lesions tissulaires
GB0018527D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Composition
GB0118251D0 (en) 2001-07-26 2001-09-19 Photocure Asa Method
GB0128052D0 (en) 2001-11-22 2002-01-16 Drug Discovery Lab As Compounds

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0316179A2 (en) * 1987-11-10 1989-05-17 Tokuyama Soda Kabushiki Kaisha Photochromic compounds
JPH0753487A (ja) * 1993-08-19 1995-02-28 Cosmo Sogo Kenkyusho:Kk 植物成長調節剤
WO1996028412A1 (en) * 1995-03-10 1996-09-19 Photocure As Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104718190A (zh) * 2012-09-03 2015-06-17 埃克塞特大学 用于光动力疗法的吡啶酮化合物
CN104718190B (zh) * 2012-09-03 2017-03-08 埃克塞特大学 用于光动力疗法的吡啶酮化合物

Also Published As

Publication number Publication date
HUP0301427A2 (hu) 2003-09-29
DE60125555T2 (de) 2007-10-11
EP1313695B1 (en) 2006-12-27
US7563819B1 (en) 2009-07-21
AU2002227495B2 (en) 2006-01-05
CA2416307C (en) 2013-01-22
AU2749502A (en) 2002-02-13
RU2246483C2 (ru) 2005-02-20
JP5010088B2 (ja) 2012-08-29
DK1313695T3 (da) 2007-04-30
EP1313695A1 (en) 2003-05-28
US7217736B2 (en) 2007-05-15
CN1460099A (zh) 2003-12-03
GB0018528D0 (en) 2000-09-13
US20040106679A1 (en) 2004-06-03
NO20030398D0 (no) 2003-01-24
ES2276844T3 (es) 2007-07-01
ATE349417T1 (de) 2007-01-15
CA2416307A1 (en) 2002-02-07
PT1313695E (pt) 2007-01-31
JP2004505105A (ja) 2004-02-19
NO20030398L (no) 2003-03-12
WO2002010120A1 (en) 2002-02-07
DE60125555D1 (de) 2007-02-08
NZ523927A (en) 2004-07-30
KR20030028554A (ko) 2003-04-08
CZ2003260A3 (cs) 2003-06-18

Similar Documents

Publication Publication Date Title
CN1318388C (zh) 在光化学疗法中作为光敏剂的5－氨基乙酰丙酸的酯类
CN1137087C (zh) 用作光化学疗法中的光致敏剂的5-氨基酮戊酸的酯
US7287646B2 (en) Esters of 5-aminolevulinic acid and their use as photosensitizing compounds in photochemotherapy
AU2002227495A1 (en) Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
JP5164565B2 (ja) ５−アミノレブリン酸又はその誘導体の酸付加塩
US7247655B2 (en) Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
RU2191010C2 (ru) Сложные эфиры 5-аминолевулиновой кислоты в качестве фотосенсибилизаторов в фотохимиотерапии

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20070530

Termination date: 20130725